Pandemic prevention

German lab developed coronavirus detection method

Investigators at Hannover Medical School (MHH) in Germany have developed a molecular assay for detecting the novel coronavirus SARS-CoV-2 (previously 2019-nCoV) on the automated Panther Fusion system by Hologic.

The preclinical assay is described online in the Journal of Clinical Virology. “Rapid diagnosis is critical to combatting the spread of pandemics, and the Panther Fusion system is well suited to this purpose,” said Albert Heim, M.D, head of molecular diagnostics at MHH. “Using inactivated virus from cell cultures and commercially available control materials, we adapted two recently published PCR protocols to run on the Panther Fusion system. Our next step will be to validate our assay on clinical samples.”

blue gloved hand holding a plate well in a medical laboratory

© MHH/Karin Kaiser

The emerging SARS-coronavirus-2 (SARS-CoV-2) can cause severe respiratory tract infections (COVID-19) and has been declared a public health emergency by the WHO. “It’s extremely gratifying to see our instrument system being used to quickly develop a response to an urgent public health threat,” said Kevin Thornal, president of the Diagnostic Solutions division at Hologic. “We specifically designed Panther Fusion and Open Access functionality to give diagnostic lab customers maximum flexibility, both for their day-to-day needs and to respond quickly to emerging threats.”

The Open Access functionality on the Panther Fusion system allows accredited medical laboratories to design and validate laboratory developed tests (LDTs) to run on the fully automated, high-throughput platform. Laboratories can run their LDTs simultaneously with commercially available CE-IVD assays in a random access model, without waiting to batch tests. Users of Open Access are required to follow all applicable local requirements for their laboratory and users in developing and validating their own LDTs on the Panther Fusion system.

The assay described has not received CE-IVD certification in Europe or clearance from the Food and Drug Administration (FDA) in the United States.


Source: Hologic

06.03.2020

Read all latest stories

Related articles

Photo

Sponsored • Lab diagnostics

Molecular scalable solutions for laboratories of every size

One size does not fit all when it comes to diagnostics. Different diagnostic locations need solutions that meet their needs, whether for on-demand testing in a healthcare setting or a laboratory…

Photo

Sponsored • Breast imaging congress

EUSOBI 2021: A turning point in women’s health

The breast imaging field plays a critical role in women’s health and wellbeing around the globe. Bringing together experts, leaders and innovators from across the breast imaging landscape, the 2021…

Photo

Sponsored • Breast cancer backlog

Getting cancer screening programmes back on track with AI and digitisation

The Covid-19 pandemic continues to impact people’s health across the world. This goes beyond the disease itself, as healthcare systems adapt how they provide services. Routine screening has been…

Related products

Hologic – 3Dimensions

Tomosynthesis

Hologic – 3Dimensions

Hologic, Inc.
Hologic -3DQuorum

Artificial Intelligence

Hologic -3DQuorum

Hologic, Inc.
Subscribe to Newsletter